✦ LIBER ✦

PRS24 THE COST-EFFECTIVENESS ANALYSIS OF VARENICLINE FOR SMOKING CESSATION IN POLAND

✍ Scribed by J Walczak; G Nogas; A Dybek-Karpiuk; J Augustynska; J Stelmachowski; M Garbacka; G Obrzut; D Pawlik

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PRS13 THE COST-EFFECTIVENESS OF VARENICL

✍ PB Poulsen; J Dollerup; H Keiding 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

PRS6 A COST-EFFECTIVENESS MODEL FOR SMOK

✍ S Viswanathan; W Neville; E Patel; S Raparla; WF McGhan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

PRS24 Cost-Effectiveness of Varenicline

✍ Walter, E.; Mercsanits, D. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PRS16 COST EFFECTIVENESS OF VARENICLINE

✍ KK Lee; VWY Lee; DP Chow 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PRS18 COST-UTILITY ANALYSIS OF VARENICLI

✍ A Igarashi; T Fukuda; K Tsutani 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

PRS22 COST-BENEFIT ANALYSIS OF VARENICLI

✍ M Barnard; J Price 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB